RESUMO
To clarify some characteristics of phosphatidylinositol glycan-class A gene (PIG-A) mutations in aplastic anemia (AA) and myelodysplastic syndrome (MDS) patients compared with those in paroxysmal nocturnal hemoglobinuria (PNH) patients, we investigated PIG-A mutations in CD59- granulocytes and CD48- monocytes from seven AA, eight MDS, and 11 PNH Japanese patients. The most frequent base or type abnormalities of the PIG-A gene in AA and MDS patients were base substitutions or missense mutations, respectively, and deletions or frameshift mutations, respectively, in PNH patients. Several PIG-A mutations, most of which were statistically minor, were found in glycosylphosphatidylinositol-negative cells from all AA and MDS patients but not from all PNH patients. However, the common PIG-A mutations during the clinical course between CD59- granulocytes and/or CD48- monocytes from each AA or MDS patient, except for Case 5, were not found. PIG-A mutations were different between the granulocytes and monocytes from five AA and five MDS patients. Our results indicate that there were some characteristics of PIG-A mutations in AA and MDS patients compared with PNH patients and that several minor PNH clones in these patients occurred at random during the clinical course. This partly explains the transformation of AA or MDS to PNH at intervals.
Assuntos
Anemia Aplástica/genética , Proteínas de Membrana/genética , Síndromes Mielodisplásicas/genética , Adulto , Anemia Aplástica/complicações , Análise Mutacional de DNA/métodos , DNA de Neoplasias/genética , Eritrócitos/química , Feminino , Regulação Leucêmica da Expressão Gênica , Frequência do Gene , Glicosilfosfatidilinositóis/deficiência , Glicosilfosfatidilinositóis/genética , Granulócitos/química , Hemoglobinúria Paroxística/genética , Humanos , Masculino , Pessoa de Meia-Idade , Monócitos/química , Mutação , Síndromes Mielodisplásicas/complicações , Sensibilidade e EspecificidadeRESUMO
Reactivation of chronic hepatitis B virus (HBV) infection in patients undergoing chemotherapy is well-documented, but reactivation during imatinib mesylate treatment has not been reported. This study reports a 54-year-old man, without prior liver dysfunction but with chronic HBV infection, in whom fatal HBV reactivation occurred during treatment of chronic myeloid leukemia (CML) with imatinib mesylate. He developed fulminant hepatitis followed by marked elevation of HBV DNA polymerase, probably from the lymphocytopenic and immunosuppressive status induced by imatinib mesylate. Imatinib mesylate is widely used to treat CML patients. Although therapy with imatinib mesylate is generally well tolerated, the case presented here suggests that viral reactivation should be considered, even when using imatinib mesylate to treat CML.
Assuntos
Antineoplásicos/efeitos adversos , Vírus da Hepatite B/fisiologia , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico , Piperazinas/efeitos adversos , Pirimidinas/efeitos adversos , Benzamidas , Evolução Fatal , Vírus da Hepatite B/efeitos dos fármacos , Humanos , Mesilato de Imatinib , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Ativação Viral/efeitos dos fármacosRESUMO
The water-in-oil droplet bilayer is a simple and useful lipid bilayer system for membrane transport analysis. The droplet interface bilayer is readily formed by the contact of two water-in-oil droplets enwrapped by a phospholipid monolayer. However, the size of individual droplets with femtoliter volumes in a high-throughput manner is difficult to control, resulting in low sensitivity and throughput of membrane transport analysis. To overcome this drawback, in this study, we developed a novel micro-device in which a large number of droplet interface bilayers (>500) are formed at a time by using femtoliter-sized droplet arrays immobilized on a hydrophobic/hydrophilic substrate. The droplet volume was controllable from 3.5 to 350 fL by changing the hydrophobic/hydrophilic pattern on the device, allowing high-throughput analysis of membrane transport mechanisms including membrane permeability to solutes (e.g., ions or small molecules) with or without the aid of transport proteins. Thus, this novel platform broadens the versatility of water-in-oil droplet bilayers and will pave the way for novel analytical and pharmacological applications such as drug screening.
Assuntos
Ensaios de Triagem em Larga Escala/instrumentação , Bicamadas Lipídicas/metabolismo , Análise em Microsséries/instrumentação , Modelos Biológicos , Fosfatidiletanolaminas/metabolismo , Fosfatidilgliceróis/metabolismo , Algoritmos , Toxinas Bacterianas/metabolismo , Transporte Biológico , Cloreto de Cálcio/metabolismo , Corantes/metabolismo , Desenho de Equipamento , Proteínas Hemolisinas/metabolismo , Interações Hidrofóbicas e Hidrofílicas , PermeabilidadeRESUMO
A single molecule of F1-ATPase is by itself a rotary motor in which a central subunit, gamma, rotates against a surrounding stator cylinder made of alpha 3 beta 3 hexamer. Driven by the three beta subunits that hydrolyse ATP sequentially, the motor runs with discrete 120 degrees steps at low ATP concentrations. Over broad ranges of load and speed, the motor produces a constant torque of 40 pN.nm. The mechanical work the motor does in the 120 degrees step, or the work per ATP hydrolysed, is also constant and amounts to 80-90 pN.nm, which is close to the free energy of ATP hydrolysis. Thus this motor can work at near 100% efficiency.
Assuntos
Trifosfato de Adenosina/metabolismo , Proteínas Motores Moleculares/fisiologia , ATPases Translocadoras de Prótons/fisiologia , Animais , HumanosRESUMO
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia that is characterized by a deficiency of glycosylphosphatidylinositol-anchored membrane proteins due to phosphatidylinositol glycan-class A (PIG-A) gene abnormalities in various lineages of peripheral blood cells and hematopoietic precursors. The purpose of our study was to clarify the distribution of PIG-A gene abnormalities among various cell lineages during differentiation and maturation in PNH patients. The expression of CD16b or CD59 in peripheral blood granulocytes or cultured erythroblasts from three Japanese PNH patients was analyzed using flow cytometry. PIG-A gene abnormalities in both cell types, including glycophorin A(+) bone marrow erythroblasts, were examined using nucleotide sequence analysis. The expression study of PIG-A genes from each patient was also performed using JY-5 cells.Flow cytometry revealed that the erythroblasts consisted of negative, intermediate, and positive populations in Cases 1 and 3 and negative and intermediate populations in Case 2. The granulocytes consisted of negative and positive populations in all three cases. DNA sequence analysis indicated that all the PNH cases had two or three types of PIG-A gene abnormalities, and that a predominant clone with an abnormal PIG-A gene was different in granulocytes and erythroblasts from Cases 2 and 3. Expression studies showed that all the mutations from the patients were responsible for the null phenotype.PIG-A gene abnormalities result in deficiencies of glycosylphosphatidylinositol-anchored proteins in PNH erythroblasts and granulocytes. The distribution of predominant PNH clones with PIG-A gene abnormalities is often heterogeneous between the cell types, suggesting that a clonal selection of PIG-A gene abnormalities occurs independently among various cell lineages during differentiation and maturation.
Assuntos
Eritroblastos/química , Granulócitos/química , Hemoglobinúria Paroxística/genética , Proteínas de Membrana/genética , Mutação , Adulto , Idoso , Antígenos CD55/análise , Antígenos CD59/análise , Diferenciação Celular , Células Cultivadas , DNA/sangue , DNA/química , Eritroblastos/imunologia , Eritrócitos/química , Feminino , Citometria de Fluxo , Glicosilfosfatidilinositóis/sangue , Glicosilfosfatidilinositóis/deficiência , Granulócitos/imunologia , Hemoglobinúria Paroxística/sangue , Humanos , Masculino , RNA Mensageiro/sangue , RNA Mensageiro/química , Receptores de IgG/análise , Análise de Sequência de DNA , Análise de Sequência de RNARESUMO
F(o)F(1)-ATP synthase mediates coupling of proton flow in F(o) and ATP synthesis/hydrolysis in F(1) through rotation of central rotor subunits. A ring structure of F(o)c subunits is widely believed to be a part of the rotor. Using an attached actin filament as a probe, we have observed the rotation of the F(o)c subunit ring in detergent-solubilized F(o)F(1)-ATP synthase purified from Escherichia coli. Similar studies have been performed and reported recently [Sambongi et al. (1999) Science 286, 1722-1724]. However, in our hands this rotation has been observed only for the preparations which show poor sensitivity to dicyclohexylcarbodiimde, an F(o) inhibitor. We have found that detergents which adequately disperse the enzyme for the rotation assay also tend to transform F(o)F(1)-ATP synthase into an F(o) inhibitor-insensitive state in which F(1) can hydrolyze ATP regardless of the state of the F(o). Our results raise the important issue of whether rotation of the F(o)c ring in isolated F(o)F(1)-ATP synthase can be demonstrated unequivocally with the approach adopted here and also used by Sambongi et al.
Assuntos
Artefatos , ATPases Translocadoras de Prótons/química , ATPases Translocadoras de Prótons/metabolismo , Rotação , Actinas/metabolismo , Trifosfato de Adenosina/metabolismo , Biopolímeros/metabolismo , Cromatografia em Gel , Detergentes/farmacologia , Dicicloexilcarbodi-Imida/farmacologia , Escherichia coli/enzimologia , Escherichia coli/genética , Hidrólise/efeitos dos fármacos , Cinética , Sondas Moleculares/metabolismo , Ligação Proteica , Conformação Proteica/efeitos dos fármacos , ATPases Translocadoras de Prótons/antagonistas & inibidores , ATPases Translocadoras de Prótons/genética , Proteínas Recombinantes de Fusão/antagonistas & inibidores , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Reprodutibilidade dos Testes , Solubilidade/efeitos dos fármacos , Desacopladores/farmacologia , Venturicidinas/farmacologiaAssuntos
Distinções e Prêmios , Bioquímica , ATPases Translocadoras de Prótons/química , ATPases Translocadoras de Prótons/metabolismo , Actinas/química , Actinas/metabolismo , Trifosfato de Adenosina/metabolismo , Bioquímica/história , Domínio Catalítico , História do Século XX , Japão , Microscopia de Fluorescência , Modelos Moleculares , Conformação Proteica , Estrutura Secundária de Proteína , Prótons , TermodinâmicaRESUMO
The percentage of complement-sensitive erythrocytes varies among patients with paroxysmal nocturnal hemoglobinuria (PNH) and is related to disease severity. We examined the changes of complement-sensitive erythrocytes following administration of androgens, prednisolone, dextran, and iron to 12 PNH patients using the complement lysis sensitivity test or flow cytometric analysis of decay accelerating factor and CD59/membrane attack complex-inhibitory factor expression for 11 years. Five untreated PNH patients were also studied as a control group. The complement-sensitive erythrocyte count remained almost constant in the control group, while it increased in four out of five patients receiving androgens. In addition, it decreased in two out of three patients receiving prednisolone, increased in both patients treated with dextran, and increased slightly in two of the three patients receiving iron therapy. Episodes of hemoglobinuria increased in three of the nine patients showing an increase of complement-sensitive erythrocytes, and decreased in four patients receiving prednisolone or dextran. A good response to treatment was clinically observed in four patients receiving androgens, in one patient treated with prednisolone, and in one patient receiving dextran according to the scoring system. These findings suggest that PNH remains stable when the number of complement-sensitive erythrocytes remains fairly constant, and that the PNH III erythrocyte count is especially related to the frequency of hemoglobinuria. Thus, it seems to be important to determine the long-term effect of drug therapy on complement-sensitive erythrocytes to select the most appropriate treatment.
Assuntos
Androgênios/farmacologia , Proteínas do Sistema Complemento/fisiologia , Dextranos/farmacologia , Eritrócitos/efeitos dos fármacos , Hemoglobinúria Paroxística/tratamento farmacológico , Hemólise/efeitos dos fármacos , Ferro/farmacologia , Prednisolona/farmacologia , Adolescente , Adulto , Idoso , Androgênios/uso terapêutico , Antígenos CD55/sangue , Complexo de Ataque à Membrana do Sistema Complemento/análise , Dextranos/uso terapêutico , Feminino , Citometria de Fluxo , Seguimentos , Hemoglobinúria Paroxística/sangue , Humanos , Ferro/uso terapêutico , Masculino , Pessoa de Meia-Idade , Prednisolona/uso terapêutico , Resultado do TratamentoRESUMO
The long period of external fixation after the completion of distraction, which is necessary to obtain enough strength for resisting without fixation is a significant disadvantage of distraction osteogenesis. The purpose of this study is to understand the mechanical property of the regenerated bone and try to find an appropriate timing for safely removing the fixation device. An external fixation device was applied to the right tibia in rabbits and transverse osteotomy was performed just below the tibio-fibula junction. The tibiae were lengthened 7.2 mm at 0.72 mm a day for 10 days after surgery. A bone mineral density (BMD) and stress strain index (SSI) analyzed by peripheral quantitative computed tomography showed a significant increase on day 40, but returned to the control level at day 64 after the completion of distraction. Therefore, the newly formed bone between the host cortical bone seemed to be enough to resist the mechanical stress on day 40 during the consolidation period in this study. The present results suggested the possibility of removing the fixation device during the period when the BMD and SSI showed a significantly high level during the consolidation period.
Assuntos
Absorciometria de Fóton , Regeneração Óssea/fisiologia , Osteogênese por Distração , Tíbia/cirurgia , Tomografia Computadorizada por Raios X/métodos , Análise de Variância , Animais , Densidade Óssea/fisiologia , Remoção de Dispositivo , Fixadores Externos , Corantes Fluorescentes , Processamento de Imagem Assistida por Computador , Masculino , Microscopia Confocal , Osteogênese por Distração/instrumentação , Osteogênese por Distração/métodos , Maleabilidade , Coelhos , Rotação , Estatística como Assunto , Estresse Mecânico , Tíbia/diagnóstico por imagem , Tíbia/patologia , Fatores de Tempo , Cicatrização/fisiologiaRESUMO
To clarify the response of endothelial cells to complement, we studied not only the reaction of endothelial cells against complement lysis sensitivity (CLS) test, but also the expression of complement regulatory proteins by two-color flow cytometric analysis and backscattered scanning immunoelectron microscopic analysis using monoclonal antibodies to decay-accelerating factor (DAF) and/or CD59. Complement activation didn't lead to the cell death of human aortic endothelial cells (HAECs) and human umbilical vein endothelial cells (HUVECs). In control, two-color flow cytometric analysis indicated that HAECs consisted of a single double-positive population for these proteins as well as HUVECs. Then, HUVECs and HAECs after the CLS test resulted in having same distribution by flow cytometry. Moreover, the microscopic analysis showed that DAF or CD59 was expressed with a diffuse distribution. However, DAF on HUVECs and CD59 on HAECs were present at the margin of cell surfaces more than at the other places. These findings suggest that endothelial cells have a defense mechanism for complement activation in vitro by the changes of expression of complement regulatory proteins on the membrane surface, and that the mechanism of HAECs to complement is the same as that of HUVECs.
Assuntos
Antígenos CD55/metabolismo , Antígenos CD59/metabolismo , Endotélio Vascular/imunologia , Anticorpos Monoclonais , Células Cultivadas , Ativação do Complemento , Endotélio Vascular/citologia , Humanos , Microscopia ImunoeletrônicaRESUMO
Thrombocytopenia due to immune mechanisms is rare and difficult to manage in elderly patients. We describe a case of an 89-year-old female with severe immune thrombocytopenia (ITP) who rapidly improved by pulse therapy with cyclophosphamide. She was admitted to our hospital because she had arthralgia in both sides of her femoral region since January 1999, aphthous stomatitis and ecchymosis of the leg since April 1999, and bloody phlegm in July 1999. On admission, her peripheral blood count revealed severe thrombocytopenia (0.1 x 10(4)/microl). Her megakaryocyte count from bone marrow was increased to 512/microl without abnormal cells. Systemic lupus erythematosus was suspected because of strong positive protein in the urine in addition to the clinical and hematological findings described above, but she was negative for all the autoantibodies examined. Finally, she was diagnosed as having ITP on the basis of high platelet associated immunoglobulin G in addition to hematological and physical findings and she was treated with prednisolone. It was difficult to maintain her platelet count with only prednisolone, but 600 mg of cyclophosphamide rapidly increased her platelet count in spite of tapering the prednisolone. In September 2000, her platelet count was kept within normal limits by administration of 15 mg/day of prednisolon. It is suggested that immunosuppressive therapy for ITP using high-dose cyclophosphamide is useful in elderly patients as well as in juvenile adult patients.
Assuntos
Ciclofosfamida/administração & dosagem , Imunossupressores/administração & dosagem , Púrpura Trombocitopênica Idiopática/tratamento farmacológico , Idoso , Idoso de 80 Anos ou mais , Feminino , HumanosRESUMO
A 55-year-old man was admitted to our department because of shortness of breath and pancytopenia on March 27, 1992. On admission, palpebral conjuctiva were anemic. Laboratory findings showed pancytopenia, a reticulocyte count of 44,835/microliters, hemosiderinuria, LDH of 710 IU/l, haptoglobin of 6 mg/dl, NAP score of 301, red cell acetylcholinesterase of 1.5 U, negative Ham's test and negative sugar water test. Bone marrow was hypoplastic (2.4 x 10(4)/microliters). The erythrocytes of this patient showed complement-sensitive cells by the complement lysis sensitivity test, and a negative population consisting of double negative erythrocytes by flow cytometric two-color analysis using monoclonal antibodies to CD55 and CD59. A diagnosis of PNH with hypoplastic bone marrow was thus made. Therefore, flow cytometric two-color analysis appears to be superior to the standard tests currently used.
Assuntos
Hemoglobinúria Paroxística/diagnóstico , Hemólise , Anticorpos Monoclonais , Antígenos CD/análise , Citometria de Fluxo/métodos , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
A 25-year-old man was admitted for evaluation of pancytopenia on May 2, 1997. On admission, he had pancytopenia with a normal reticulocyte count. Bone marrow aspirate specimens displayed a normal karyotype and hypocellularity without myelodysplasia. Although total bilirubin and lactate dehydrogenase levels were within their normal ranges, the haptoglobin level was low; additionally, two-color flow cytometric analysis determined that 3.3% of erythrocytes were double-negative for CD55 and CD59 expression. Atypical paroxysmal nocturnal hemoglobinuria with bone marrow hypoplasia was diagnosed. Because initial treatment with cyclosporin A was not effective, the patient was subsequently given a combination of antithymocyte globulin, cyclosporin A, and granulocyte colony-stimulating factor. Although the pancytopenia subsided, the percentage of double-negative erythrocytes in the patient's blood remained almost unchanged compared to findings obtained on admission.
Assuntos
Soro Antilinfocitário/uso terapêutico , Doenças da Medula Óssea/complicações , Ciclosporina/uso terapêutico , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Hemoglobinúria Paroxística/terapia , Imunossupressores/uso terapêutico , Adulto , Doenças da Medula Óssea/patologia , Quimioterapia Combinada , Hemoglobinúria Paroxística/patologia , Humanos , Masculino , Resultado do TratamentoRESUMO
To establish the guideline for nutrition in the very old, we analyzed biochemical and hematological data from 45 Japanese centenarians living in Tokyo metropolitan area during 1994 and 1995. Levels of cholesterol, HDL-cholesterol, apolipoprotein A1 and B, albumin, prealbumin in serum were lower than in a control group or lower than the reference range, which indicates that these centenarians were undernourished. RBC counts, hemoglobin, and hematocrit were also low in the centenarians. The concentration of albumin correlated positively with those of HDL-cholesterol and apolipoprotein A1, and negatively with concentration of Lp(a). The value for transferrin correlated positively with energy intake and with the concentration of apolipoprotein A1. The concentration of prealbumin correlated positively with the concentration of hemoglobin, hematocrit and the total cholesterol concentration. According to their nutritional status, the centenarians were divided into 2 groups: well-nourished and undernourished. Those who were well-nourished had higher levels of cholesterol, HDL, Hb, and apolipoprotein A1, their levels of ADL and cognitive function were also high. The findings of blood-chemical data in the centenarians may be partly due to undernutrition. Centenarians who were well-nourished were considered to be aging successfully. These results and others previously published indicate that the concentrations of albumin, prealbumin, transferrin and either CRI or IL-6 are useful for nutritional assessment in the very old.
Assuntos
Idoso de 80 Anos ou mais/fisiologia , Estado Nutricional , Idoso , Feminino , Humanos , Interleucina-6/sangue , Masculino , Pré-Albumina/análise , Albumina Sérica/análise , Tóquio , Transferrina/análiseRESUMO
Rapid demographic aging has made caring for the elderly an increasingly important social issue in Japan. To study current conditions of the oldest elderly citizens, we investigated the dietary practices of centenarians in the Tokyo metropolitan area. First, we compared the food intake of centenarians with that of octogenarians. Next, to identify dietary trends, we investigated whether food intake by centenarians had changed significantly between 1981 and 1995. Nutritional intake by the centenarians and octogenarians in 1995 was about 60% and 75% that of the control, respectively. However, the nutritional intake of well nourished centenarians was similar to that of the octogenarians. Cognitive function and daily activity have an influence on nutritional intake. The centenarians were similar to the control subjects in their consumption of dairy products, sweets, and fruit. However, their intake of cereals, meat, fish, and fatty oils was loss than 60% that of the control, which indicates their preference for soft and sugary foods. The pattern of dietary practices of centenarians in 1981 was similar. Although the total food intake of centenarians amounted to 60% of the control in 1995 energy intake per kilogram of body weight averaged over 30 kcal. As to dietary trends, centenarians in 1981 are more cereals, eggs, algae products, and legumes than did their 1995 counterparts. This finding seems to reflect a generational difference in dietary habits.
Assuntos
Comportamento Alimentar , Atividades Cotidianas , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Japão , Masculino , Avaliação NutricionalRESUMO
The emission transition dipole moments of single-molecule free-base phthalocyanines at an air/glass interface were visualized using defocused wide-field fluorescence microscopy at a temporal resolution of 100-200 ms. Isolated molecules showed slow proton tautomerization, which is consistent with previous theoretical calculations in the gas phase, which predicted large activation energies.